• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白尿和糖尿病对心血管事件风险的交互作用:前瞻性队列 CKD-ROUTE 研究。

Interaction of proteinuria and diabetes on the risk of cardiovascular events: a prospective cohort CKD-ROUTE study.

机构信息

Department of Endocrinology and Metabolism, First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330006, People's Republic of China.

Jiangxi Clinical Research Center for Endocrine and Metabolic Disease, Nanchang, 330006, People's Republic of China.

出版信息

BMC Public Health. 2024 Nov 18;24(1):3192. doi: 10.1186/s12889-024-20715-2.

DOI:10.1186/s12889-024-20715-2
PMID:39558295
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11572061/
Abstract

OBJECTIVE

We evaluated the interaction of urinary protein-to-creatinine ratio (UPCR) with diabetes on the risk of cardiovascular events in a cohort study.

METHODS

The study population consisted of 639 participants with chronic kidney disease (CKD) stages 2-5, enrolled between 2010 and 2011 in Japan. Cox proportional hazards models were used to evaluate the independent and combined effects of the UPCR and diabetes on cardiovascular events.

RESULTS

During a median follow-up of 3 years, 59 participants developed cardiovascular events during follow-up. A notably higher risk of cardiovascular events was found in participants with proteinuria [hazards ratio (HR): 2.16, 95% confidence interval (95% CI): 1.17-3.97] compared to those without proteinuria at UPCR levels. In addition, the participants with diabetes had a higher risk of cardiovascular events (HR: 2.53, 95% CI: 1.49-4.30) than those without diabetes. Moreover, an interaction was found between UPCR and diabetes on cardiovascular events (P for interaction = 0.04). Participants with both proteinuria (UPCR ≥ 0.5 g/gCr) and diabetes had a 4.09 times higher risk of cardiovascular events (HR: 4.09, 95% CI: 1.97-8.47) compared with those without proteinuria (UPCR < 0.5 g/gCr) and diabetes.

CONCLUSIONS

In summary, among participants with CKD stages 2-5, proteinuria and diabetes were found to independently and jointly affect the risk of cardiovascular events. Participants with proteinuria and diabetes had the highest risk of cardiovascular events compared with other groups.

摘要

目的

我们在一项队列研究中评估了尿蛋白与肌酐比值(UPCR)与糖尿病之间的相互作用对心血管事件风险的影响。

方法

研究人群包括 2010 年至 2011 年在日本登记的 639 名慢性肾脏病(CKD)2-5 期患者。使用 Cox 比例风险模型评估 UPCR 和糖尿病对心血管事件的独立和联合作用。

结果

在中位随访 3 年期间,59 名参与者在随访期间发生心血管事件。与 UPCR 水平无蛋白尿的参与者相比,蛋白尿患者发生心血管事件的风险明显更高[风险比(HR):2.16,95%置信区间(95%CI):1.17-3.97]。此外,患有糖尿病的参与者发生心血管事件的风险高于无糖尿病的参与者(HR:2.53,95%CI:1.49-4.30)。此外,还发现 UPCR 和糖尿病对心血管事件存在交互作用(P 交互=0.04)。同时患有蛋白尿(UPCR≥0.5 g/gCr)和糖尿病的参与者发生心血管事件的风险比无蛋白尿(UPCR<0.5 g/gCr)和无糖尿病的参与者高 4.09 倍(HR:4.09,95%CI:1.97-8.47)。

结论

综上所述,在 CKD 2-5 期患者中,蛋白尿和糖尿病独立且共同影响心血管事件的风险。与其他组相比,同时患有蛋白尿和糖尿病的参与者发生心血管事件的风险最高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf5b/11572061/96ffe2212629/12889_2024_20715_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf5b/11572061/7291d5635b3c/12889_2024_20715_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf5b/11572061/96ffe2212629/12889_2024_20715_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf5b/11572061/7291d5635b3c/12889_2024_20715_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf5b/11572061/96ffe2212629/12889_2024_20715_Fig2_HTML.jpg

相似文献

1
Interaction of proteinuria and diabetes on the risk of cardiovascular events: a prospective cohort CKD-ROUTE study.蛋白尿和糖尿病对心血管事件风险的交互作用:前瞻性队列 CKD-ROUTE 研究。
BMC Public Health. 2024 Nov 18;24(1):3192. doi: 10.1186/s12889-024-20715-2.
2
Body mass index modifies the effect of urinary protein-to-creatinine ratio on chronic kidney disease progression.体重指数会改变尿蛋白/肌酐比值对慢性肾脏病进展的影响。
Int Urol Nephrol. 2024 Jul;56(7):2371-2378. doi: 10.1007/s11255-024-03984-z. Epub 2024 Feb 26.
3
Urine creatinine concentration influences the prognostic value of proteinuria for MACE prediction from the findings of the KNOW-CKD study.尿肌酐浓度影响 KNOW-CKD 研究中蛋白尿对 MACE 预测的预后价值。
Sci Rep. 2022 Sep 23;12(1):15924. doi: 10.1038/s41598-022-19819-9.
4
Time-Updated Changes in Estimated GFR and Proteinuria and Major Adverse Cardiac Events: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.基于慢性肾脏病预后质量倡议(CRIC)研究的估算肾小球滤过率和蛋白尿的时间更新变化与主要不良心脏事件的相关性
Am J Kidney Dis. 2022 Jan;79(1):36-44.e1. doi: 10.1053/j.ajkd.2021.03.021. Epub 2021 May 28.
5
Nonlinear association between proteinuria levels and the risk of cardiovascular disease events and all-cause mortality among chronic kidney disease patients.蛋白尿水平与慢性肾脏病患者心血管疾病事件和全因死亡率风险之间的非线性关联。
Ren Fail. 2024 Dec;46(1):2310727. doi: 10.1080/0886022X.2024.2310727. Epub 2024 Feb 12.
6
A comparison of the utility of the urine dipstick and urine protein-to-creatinine ratio for predicting microalbuminuria in patients with non-diabetic lifestyle-related diseases -a comparison with diabetes.非糖尿病生活方式相关疾病患者中尿试纸与尿蛋白/肌酐比值在预测微量白蛋白尿方面的效用比较-与糖尿病的比较。
BMC Nephrol. 2022 Nov 24;23(1):377. doi: 10.1186/s12882-022-02974-6.
7
Reduction and residual proteinuria are therapeutic targets in type 2 diabetes with overt nephropathy: a post hoc analysis (ORIENT-proteinuria).在显性肾病的 2 型糖尿病中,减少和减少蛋白尿是治疗目标:事后分析(ORIENT-蛋白尿)。
Nephrol Dial Transplant. 2013 Oct;28(10):2526-34. doi: 10.1093/ndt/gft249. Epub 2013 Sep 7.
8
Predictive value of spot versus 24-hour measures of proteinuria for death, end-stage kidney disease or chronic kidney disease progression.蛋白尿即时检测值与24小时检测值对死亡、终末期肾病或慢性肾病进展的预测价值。
BMC Nephrol. 2018 Mar 7;19(1):55. doi: 10.1186/s12882-018-0853-1.
9
Prediction of microalbuminuria from proteinuria in chronic kidney disease due to non-diabetic lifestyle-related diseases: comparison with diabetes.非糖尿病生活方式相关疾病导致的慢性肾脏病中蛋白尿对微量白蛋白尿的预测:与糖尿病的比较。
Clin Exp Nephrol. 2021 Jul;25(7):727-750. doi: 10.1007/s10157-021-02027-6. Epub 2021 Mar 3.
10
Association of cholesterol levels with mortality and cardiovascular events among patients with CKD and different amounts of proteinuria.胆固醇水平与不同蛋白尿程度的 CKD 患者的死亡率和心血管事件的关系。
Clin J Am Soc Nephrol. 2013 Nov;8(11):1915-26. doi: 10.2215/CJN.02350213. Epub 2013 Aug 8.

引用本文的文献

1
Plasma Thrombospondin-1 in Etiology-Specific Associations with Proteinuria Events in Pediatric Chronic Kidney Disease.血浆血小板反应蛋白-1与儿童慢性肾脏病蛋白尿事件的病因特异性关联
Children (Basel). 2025 Aug 21;12(8):1101. doi: 10.3390/children12081101.

本文引用的文献

1
Cardiovascular Outcomes in Patients With Diabetes and Kidney Disease: JACC Review Topic of the Week.患有糖尿病和肾脏疾病患者的心血管结局:JACC 本周综述专题
J Am Coll Cardiol. 2023 Jul 11;82(2):161-170. doi: 10.1016/j.jacc.2023.04.052.
2
Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association.《心脏病与卒中统计数据-2023 更新:美国心脏协会报告》。
Circulation. 2023 Feb 21;147(8):e93-e621. doi: 10.1161/CIR.0000000000001123. Epub 2023 Jan 25.
3
Predictive Risk Models to Identify Patients at High-Risk for Severe Clinical Outcomes With Chronic Kidney Disease and Type 2 Diabetes.
预测风险模型以识别患有慢性肾脏病和 2 型糖尿病的高危患者的严重临床结局。
J Prim Care Community Health. 2022 Jan-Dec;13:21501319211063726. doi: 10.1177/21501319211063726.
4
SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.SGLT2 抑制剂在 2 型糖尿病中的 CKD 和心血管疾病的作用:由美国国家肾脏基金会赞助的科学研讨会报告。
Diabetes. 2021 Jan;70(1):1-16. doi: 10.2337/dbi20-0040. Epub 2020 Oct 26.
5
The angiotensin II receptor-neprilysin inhibitor LCZ696 attenuates the progression of proteinuria in type 2 diabetic rats.血管紧张素 II 受体-脑啡肽酶抑制剂 LCZ696 可减轻 2 型糖尿病大鼠蛋白尿的进展。
J Pharmacol Sci. 2020 Mar;142(3):124-126. doi: 10.1016/j.jphs.2019.09.014. Epub 2019 Dec 17.
6
Impaired glucose tolerance and albuminuria in patients with chronic heart failure: a subanalysis of the SUPPORT trial.慢性心力衰竭患者的葡萄糖耐量受损和白蛋白尿:SUPPORT 试验的亚分析。
ESC Heart Fail. 2019 Dec;6(6):1252-1261. doi: 10.1002/ehf2.12516. Epub 2019 Oct 24.
7
Renal and Cardiovascular Risk According to Tertiles of Urinary Albumin-to-Creatinine Ratio: The Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT).根据尿白蛋白与肌酐比值的三分位数评估肾脏和心血管风险:青少年 1 型糖尿病心脏肾脏干预试验(AdDIT)。
Diabetes Care. 2018 Sep;41(9):1963-1969. doi: 10.2337/dc18-1125. Epub 2018 Jul 19.
8
Prognosis of chronic kidney disease with normal-range proteinuria: The CKD-ROUTE study.正常蛋白尿范围的慢性肾脏病的预后:CKD-ROUTE研究
PLoS One. 2018 Jan 17;13(1):e0190493. doi: 10.1371/journal.pone.0190493. eCollection 2018.
9
Glycemic control in type 2 diabetes: from medication nonadherence to residual vascular risk.2 型糖尿病的血糖控制:从药物不依从到残余血管风险。
Endocrine. 2018 Jul;61(1):23-27. doi: 10.1007/s12020-017-1517-9. Epub 2018 Jan 10.
10
Cardiovascular Outcomes According to Urinary Albumin and Kidney Disease in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From the SAVOR-TIMI 53 Trial.心血管结局与 2 型糖尿病高心血管风险患者的尿白蛋白和肾脏疾病的关系:来自 SAVOR-TIMI 53 试验的观察。
JAMA Cardiol. 2018 Feb 1;3(2):155-163. doi: 10.1001/jamacardio.2017.4228.